CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Director sold 2,000 shares at $68.67 ($137,333)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 4 Planned sale Chief Financial Officer sold 131,687 shares at an average $76.61 ($10,089,164)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 11,000 shares at $80.89 ($889,790)
- 4 Planned sale Director sold 16,000 shares at $79.50 ($1,272,000)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale Director sold 10,300 shares at $69.50 ($715,850)
- 4 Planned sale President & CEO sold 216,130 shares at an average $70.83 ($15,308,553)
- 144 Insider Sale of Securities
Page 6 of 33 · 652 filings